NASDAQ · Medical - Devices

Align Technology, Inc. (ALGN) Stock

$142.71 +1.19% NASDAQ: ALGN Healthcare

Valuation

MetricValue
Price$142.71
Market Cap$10.22B
P/E Ratio25.48
P/B Ratio2.48
P/S Ratio2.54
EPS (TTM)$5.65
52-Week High$200.44
52-Week Low$123.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.09%
ROA6.44%
ROCE12.24%
Gross Margin67.68%
Operating Margin14.44%
Net Margin9.99%
Debt/Equity0.03
Current Ratio1.36

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0B$3.7B$3.9B$4.0B$4.0B
Operating Profit$976.0M$643.0M$643.0M$608.0M$616.0M
Net Profit$772.0M$362.0M$445.0M$421.0M$410.0M
EPS$9.69$4.61$5.81$5.62$5.65
Op Margin24.7%17.2%16.7%15.2%15.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.9B$5.9B$6.1B$6.2B$6.2B
Total Liabilities$2.3B$2.3B$2.5B$2.4B$2.2B
Cash$1.1B$942.0M$937.0M$1.0B$1.1B
Borrowings$125.0M$127.0M$127.0M$119.0M$114.0M

Latest News

Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus Zacks · Jul 20, 2026 Leerink Partners Adjusts Price Target on Align Technology to $235 From $230, Maintains Outperform Rating MT Newswires · Jul 20, 2026 What Could Reignite Accenture Stock From Here? Trefis · Jul 17, 2026 Cheniere Energy (LNG) Appoints Britt Vitalone As It Reworks Key Credit Lines Simply Wall St. · Jul 16, 2026 Is This the Right Time to Hold MYGN Stock in Your Portfolio? Zacks · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.2B$569.0M$786.0M$738.0M$593.0M
Investing Cash Flow$-965.0M$-505.0M$-374.0M$-370.0M$-215.0M
Financing Cash Flow$-484.0M$-528.0M$-625.0M$-381.0M$-486.0M
Net Cash Flow$139.0M$-158.0M$-4.0M$106.0M$51.0M
Free Cash Flow$771.0M$277.0M$608.0M$623.0M$491.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-8.89
EV / EBITDA12.12
FCF Yield7.19%
Quick Ratio1.28
Interest Coverage352.85
Return 1Y7.57%
Return 3Y-50.31%
Return 5Y-78.61%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
MLSSMilestone Scientific, Inc. $0.35 -2.78% -7.97 $30.96M 0.00%
NVSTEnvista Holdings Corporation $23.00 +1.23% 39.76 $3.74B 0.00%
SAUHYStraumann Holding AG $11.88 -2.62% 43.24 $18.94B 1.09%
XRAYDENTSPLY SIRONA Inc. $8.83 +1.61% -3.30 $1.77B 7.08%

About Align Technology, Inc.

Align Technology, Inc. is led by CEO Joseph Hogan, employs 20,290 people, headquartered in Tempe, US, publicly traded since 2001.

Align Technology, Inc. (ALGN) stock trades at $142.71 with a market capitalization of $10.22B. The stock is valued at a price-to-earnings (P/E) ratio of 25.48, price-to-book of 2.48, price-to-sales of 2.54. Over the past 52 weeks the stock has ranged between $123.02 and $200.44, and currently trades 28.8% below its 52-week high.

On profitability, Align Technology, Inc. generates a return on equity (ROE) of 10.09%, return on capital employed of 12.24%, an operating margin of 14.44%, a net profit margin of 9.99%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides